Skip to main content
. 2023 Sep 8;2023(9):CD014805. doi: 10.1002/14651858.CD014805.pub2

12.1. Analysis.

12.1

Comparison 12: Platinum‐based chemotherapy versus platinum free chemotherapy without Nasr 2015 or BrigTNess comparison 1, and using bevacizumab‐free CALGB, Outcome 1: Disease‐free survival